The median fold decrease of the RUNX1/RUNX1T1 transcript level was 200 (1-358000), and 16.7% (5/30) patients achieved >3 log decrease after one cycle of the HAA regimen.     ///    The RUNX1/RUNX1T1 transcript level was assessed by RT-qPCR. 